Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
about
Subependymal giant cell astrocytoma (SEGA): a case report and review of the literatureA Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Neuroimaging of phakomatoses: overview and advances.The clinical characteristics of subependymal giant cell astrocytoma: five casesAssociation between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study.EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complexTuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patientsImaging Manifestations of a Subependymal Giant Cell Astrocytoma in Tuberous SclerosisResponse to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology.Treatment of Renal Angiomyolipoma and Other Hamartomas in Patients with Tuberous Sclerosis Complex.mTOR-Dependent Cell Proliferation in the Brain.Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence.Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).The effects of everolimus on tuberous sclerosis-associated lesions can be dramatic but may be impermanent.Mammalian Target of Rapamycin Inhibitor Induced Complete Remission of a Recurrent Subependymal Giant Cell Astrocytoma in a Patient Without Features of Tuberous Sclerosis Complex.Tuberous sclerosis complex: Five new things.Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants.Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis (the EMINENTS study).CD99: A potential Diagnostic Marker for Differentiating Sub-ependymal Giant Cell Astrocytoma From Other Mimickers: A Report of Five Cases.Progressive cystic lesion in a middle-aged patient with tuberous sclerosis complex: A case report.[Hereditary tumor syndromes in neuropathology].Effects of everolimus on tuberous sclerosis complex-associated renal angiomyolipoma: A preliminary report.
P2860
Q28072113-546B7D6A-7375-4181-AD31-FBD71582993EQ30252766-355FFF53-A120-498A-9196-859D047AA5B4Q30991999-FA7BA8CA-737A-409D-80A8-8109301179FBQ35589678-A70657F8-4975-4199-9AD1-C53A6B90507CQ35836319-8D1AAF15-C4CE-4DA7-96C9-A19231053E97Q36063084-D1A33D94-497E-4A29-879C-31DF83AFC06AQ36098018-590D5677-A372-41EC-81B7-91B37A342534Q36241426-0AFA51ED-D8F3-4753-A60D-F2F6E12B3189Q36578341-CE1461B0-4E9E-4859-AD28-482F9EC1B3A2Q36695749-9DF19263-B531-403F-8C24-855FDB338428Q38755497-1D143BBC-A39E-4E55-9443-97E3635CF637Q38798392-0DDDC142-18C2-4C0F-AC19-A8C2B94BBFC3Q39182861-473C5CA2-FF16-4F5E-BEB5-8585D911F068Q47231432-2C026B6A-6C4E-4E61-85C6-A36AE052D79AQ48022730-F31D2251-1667-457E-9DAC-BE8371B89326Q48199876-CF5C637A-81A1-4236-8EC9-878243F26249Q48560554-535AD303-5319-4C5C-8362-BB07ABC0EE8DQ48869488-F069C607-599E-47F9-A037-F8DBD938781BQ49360253-5D380AC3-12E9-41CD-BA08-90EDB77B6B62Q50174779-E0E4516A-BA8B-473F-8B48-58526A067254Q51061331-B6979A1A-10D5-4804-8C39-BADD6A909434Q51734513-65895A9C-BC87-42FA-87FB-6EBDDB7BA33DQ52324849-D06C0F3A-46D3-48A6-84BD-FACF1B26F050Q53312284-B717E592-3537-46AD-B6B5-0B3515D5DADDQ53578553-EBF25351-7F00-48A8-9012-3B11B2D8AA48
P2860
Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Subependymal giant cell astroc ...... lex Consensus Conference 2012.
@en
Subependymal giant cell astroc ...... lex Consensus Conference 2012.
@nl
type
label
Subependymal giant cell astroc ...... lex Consensus Conference 2012.
@en
Subependymal giant cell astroc ...... lex Consensus Conference 2012.
@nl
prefLabel
Subependymal giant cell astroc ...... lex Consensus Conference 2012.
@en
Subependymal giant cell astroc ...... lex Consensus Conference 2012.
@nl
P2093
P1433
P1476
Subependymal giant cell astroc ...... lex Consensus Conference 2012.
@en
P2093
David N Franz
E Steve Roach
Henry Z Wang
Howard L Weiner
Jonathan Roth
Mary Kay Koenig
P304
P356
10.1016/J.PEDIATRNEUROL.2013.08.017
P577
2013-10-15T00:00:00Z